Evidence map›Paper›PMID 29439731›Full record

ArticleMicrobiome2018

MetaLonDA: a flexible R package for identifying time intervals of differentially abundant features in metagenomic longitudinal studies.

Ahmed A Metwally, Jie Yang, Christian Ascoli, Yang Dai, Patricia W Finn, David L Perkins

Abstract read
In one paragraph

Article in Microbiome, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 31 papers.

0numbers the graph read from it
0cells of the map it votes in
31citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

31 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Postbiotics fromFrontiers in microbiology · 2024
    Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Observational
  12. Article
  13. Article
  14. Article
  15. A Survey of Statistical Methods for Microbiome Data Analysis.Frontiers in applied mathematics and statistics · 2022
    Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Ahmed A MetwallyDepartment of Bioengineering, University of Illinois at Chicago, Chicago, 60607, IL, USA.ORCID 0000-0002-0155-7412
Jie YangDepartment of Mathematics, Statistics, and Computer Science, University of Illinois at Chicago, Chicago, 60607, IL, USA.
Christian AscoliDepartment of Medicine, University of Illinois at Chicago, Chicago, 60612, IL, USA.
Yang DaiDepartment of Bioengineering, University of Illinois at Chicago, Chicago, 60607, IL, USA. yangdai@uic.edu.
Patricia W FinnDepartment of Medicine, University of Illinois at Chicago, Chicago, 60612, IL, USA. pwfinn@uic.edu.
David L PerkinsDepartment of Bioengineering, University of Illinois at Chicago, Chicago, 60607, IL, USA. perkinsd@uic.edu.

Funding

Strengthening Stakeholder Engagement in Human Research Protections.UL1TR002003 · NCATS · UNIVERSITY OF ILLINOIS AT CHICAGO · PI KARNIK, NIRANJAN SUBHASH, MERMELSTEIN, ROBIN J. · 2016 to 2024
$33.7M
Precision Medicine in SarcoidosisR01HL138628 · NHLBI · UNIVERSITY OF ILLINOIS AT CHICAGO · PI JACOBSON, JEFFREY R, PERKINS, DAVID LINN · 2018 to 2021
$3.6M
The microbiota and allograft rejection: novel investigations into the consequences of obesityU01AI132898 · NIAID · BRIGHAM AND WOMEN'S HOSPITAL · PI ALEGRE, MARIA-LUISA, PERKINS, DAVID LINN · 2017 to 2021
$2.3M
National Institute of Allergy and Infectious Diseases U01AI132898NCATS NIH HHS UL1 TR002003NHLBI NIH HHS R01 HL138628NHLBI NIH HHS R01HL138628NIAID NIH HHS U01 AI132898UIC CCTS UL1TR002003
6 · The paper itself

Abstract

backgroundMicrobial longitudinal studies are powerful experimental designs utilized to classify diseases, determine prognosis, and analyze microbial systems dynamics. In longitudinal studies, only identifying differential features between two phenotypes does not provide sufficient information to determine whether a change in the relative abundance is short-term or continuous. Furthermore, sample collection in longitudinal studies suffers from all forms of variability such as a different number of subjects per phenotypic group, a different number of samples per subject, and samples not collected at consistent time points. These inconsistencies are common in studies that collect samples from human subjects.

resultsWe present MetaLonDA, an R package that is capable of identifying significant time intervals of differentially abundant microbial features. MetaLonDA is flexible such that it can perform differential abundance tests despite inconsistencies associated with sample collection. Extensive experiments on simulated datasets quantitatively demonstrate the effectiveness of MetaLonDA with significant improvement over alternative methods. We applied MetaLonDA to the DIABIMMUNE cohort ( https://pubs.broadinstitute.org/diabimmune ) substantiating significant early lifetime intervals of exposure to Bacteroides and Bifidobacterium in Finnish and Russian infants. Additionally, we established significant time intervals during which novel differentially relative abundant microbial genera may contribute to aberrant immunogenicity and development of autoimmune disease.

conclusionMetaLonDA is computationally efficient and can be run on desktop machines. The identified differentially abundant features and their time intervals have the potential to distinguish microbial biomarkers that may be used for microbial reconstitution through bacteriotherapy, probiotics, or antibiotics. Moreover, MetaLonDA can be applied to any longitudinal count data such as metagenomic sequencing, 16S rRNA gene sequencing, or RNAseq. MetaLonDA is publicly available on CRAN ( https://CRAN.R-project.org/package=MetaLonDA ).

Indexed as

BacteroidesBifidobacteriumFinlandHigh-Throughput Nucleotide SequencingHumansInfantLongitudinal StudiesMetagenomicsRNA, Ribosomal, 16SRussiaSoftwareRNA, Ribosomal, 16SDifferential abundanceLongitudinal studiesMetagenomicsMicrobiomeNegative binomial distributionSmoothing splinesTime series

Identifiers

PMID29439731
PMCPMC5812052

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.